Literature DB >> 9114137

Pneumonia and bacteremia due to Mycobacterium celatum masquerading as Mycobacterium xenopi in patients with AIDS: an underdiagnosed problem?

C A Zurawski1, G D Cage, D Rimland, H M Blumberg.   

Abstract

A newly described species of mycobacteria, Mycobacterium celatum, has rarely been reported as a cause of localized and disseminated human disease and can easily be misidentified as Mycobacterium xenopi when identification is based on biochemical testing alone. We report two cases of pneumonia and bacteremia due to M. celatum in patients with AIDS. In one case, diagnosis and initiation of therapy were delayed by misidentification of the infecting organism as M. xenopi. Genomic analysis or high-performance liquid chromatography is necessary to distinguish the two species. The finding in our two cases and a review of existing literature indicate that pulmonary disease may be an important manifestation of infection with M. celatum, especially in patients with AIDS. Further studies are needed to determine the incidence and clinical relevance of this organism in patients with AIDS and the optimal treatment regimens.

Entities:  

Mesh:

Year:  1997        PMID: 9114137     DOI: 10.1093/clinids/24.2.140

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  8 in total

1.  Necessity of quality-controlled 16S rRNA gene sequence databases: identifying nontuberculous Mycobacterium species.

Authors:  C Y Turenne; L Tschetter; J Wolfe; A Kabani
Journal:  J Clin Microbiol       Date:  2001-10       Impact factor: 5.948

2.  Successful treatment of Mycobacterium celatum pulmonary disease in an immunocompetent patient using antimicobacterial chemotherapy and combined pulmonary resection.

Authors:  Hee-Jung Jun; Nam Yong Lee; Jhingook Kim; Won-Jung Koh
Journal:  Yonsei Med J       Date:  2010-11       Impact factor: 2.759

3.  Mycobacterium celatum infection in two HIV-infected patients treated prophylactically with rifabutin.

Authors:  Y Gholizadeh; A Varnerot; C Maslo; B Salauze; H Badaoui; V Vincent; A Buré-Rossier
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-04       Impact factor: 3.267

4.  Application of the Sherlock Mycobacteria Identification System using high-performance liquid chromatography in a clinical laboratory.

Authors:  J A Kellogg; D A Bankert; G S Withers; W Sweimler; T E Kiehn; G E Pfyffer
Journal:  J Clin Microbiol       Date:  2001-03       Impact factor: 5.948

5.  Misidentification and diagnostic delay Caused by a false-positive amplified Mycobacterium tuberculosis direct test in an immunocompetent patient with a Mycobacterium celatum infection.

Authors:  J H Tjhie; A F van Belle; M Dessens-Kroon; D van Soolingen
Journal:  J Clin Microbiol       Date:  2001-06       Impact factor: 5.948

6.  Differential requirement for interferon-gamma to restrict the growth of or eliminate some recently identified species of nontuberculous mycobacteria in vivo.

Authors:  S Ehlers; E Richter
Journal:  Clin Exp Immunol       Date:  2001-05       Impact factor: 4.330

Review 7.  Impact of genotypic studies on mycobacterial taxonomy: the new mycobacteria of the 1990s.

Authors:  Enrico Tortoli
Journal:  Clin Microbiol Rev       Date:  2003-04       Impact factor: 26.132

8.  Mycobacterium celatum pulmonary infection.

Authors:  R McMullan; J Xu; T Stanley; J E Moore; B C Millar; M Wylie; C Goldsmith; R Shepherd
Journal:  Ulster Med J       Date:  2003-11
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.